Patent · US Active

Human papilloma virus replication inhibitors

US10543218B2 · kind B2 · utility

0Cited by

1References

1Claims

0Family size

Assignee

Icosagen Cell Factory OÜ · EE

Inventors

Mart Ustav, Sr. · Õssu, EE
Ene Ustav · Tartu, EE
Andres Männik · Õssu, EE
Mart Toots · Õssu, EE
Andres Tover · Tartu, EE

Key dates

Filing date	May 11, 2016
Grant date	Jan 28, 2020
Priority date	—
Expiry date	May 11, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel antiviral compounds for inhibiting one or more phases of HPV replication cycle are disclosed. Moreover, a mechanism for the inhibition is suggested and targets for further antiviral compounds are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.